01 6Hemlibra
Main Therapeutic Indication : Hematology
Currency : USD
2019 Revenue in Millions : 1,421
2018 Revenue in Millions : 231
Growth (%) : 516
Main Therapeutic Indication : Hematology
Currency : USD
2020 Revenue in Millions : 2,440
2019 Revenue in Millions : 1,538
Growth (%) : 59
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 3,252
2020 Revenue in Millions : 2,321
Growth (%) : 38
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 4,179
2021 Revenue in Millions : 3,252
Growth (%) : 29
Main Therapeutic Indication : Rare Diseases
Currency : USD
2023 Revenue in Millions : 4,811
2022 Revenue in Millions : 4,179
Growth (%) : 8
Main Therapeutic Indication : Hematology
Currency : USD
2024 Revenue in Millions : 4,961
2023 Revenue in Millions : 4,811
Growth (%) : 3
